COMMUNIQUÉS West-GlobeNewswire

Abacus Analytics Receives HFMA Peer Review Designation

17/01/2025 - 16:30

CHICAGO, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) recently reviewed Abacus Analytics’ “Usual, Customary and Reasonable Determination Report” methodology using the Peer [...]

Bionet America, Inc. Launches Super Air Smart ICU

17/01/2025 - 17:28

TUSTIN, Calif., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Bionet America, Inc. today announced the launch of the new Super Air Smart Intensive Care Unit (ICU), providing a spacious, comfortable, and high-tech environment [...]

GUERBET : Bilan semestriel du contrat de liquidité

17/01/2025 - 18:00

Bilan semestriel du contrat de liquidité Villepinte, le 17 janvier 2025 Au titre du contrat de liquidité confié par la société GUERBET à BNP Paribas, en date de dénouement du 31 décembre 2024, les moyens suivants [...]

Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025

17/01/2025 - 19:15

LAKEWOOD, Colo., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2025 at approximately 8:00 A.M. Eastern [...]

Cannabis Means Business (CMB), New York Global Edition, Opens Registration

17/01/2025 - 20:35

Experience the Premier Trade Show & Conference, June 4-5, For Cannabis Industry Professionals NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- via IBN – Cannabis Means Business (CMB), the premier business to business [...]

Scorpius Holdings Cancels Planned Reverse Stock Split

17/01/2025 - 21:13

DURHAM, N.C., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today announced [...]

Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4)

17/01/2025 - 22:00

WATERTOWN, Mass., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for [...]

Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.

17/01/2025 - 22:20

Portage, Michigan, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) today announced that it is commencing, through a wholly owned subsidiary, Eagle 1 Merger Sub, Inc., a cash tender offer to purchase all of the [...]

Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

17/01/2025 - 22:30

WALTHAM, Mass., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living [...]

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

17/01/2025 - 22:30

NOVATO, Calif., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare [...]

Santhera Receives Positive NICE Final Guidance for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy

16/01/2025 - 07:00

Santhera has begun launch preparations for AGAMREE® in UK with first sales expected in this quarter Pratteln, Switzerland, January 16, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces that the National Institute [...]

Phonak expands award-winning Infinio portfolio with two new custom hearing aids

16/01/2025 - 08:00

Phonak, a leading global provider of life-changing hearing solutions, is proud to announce the expansion of its highly acclaimed Infinio technology platform with the introduction of two new in-the-ear (ITE) hearing aids [...]

Actimed Therapeutics appoints Dr Fabio Dorigotti as Chief Medical Officer to drive further pipeline development for cancer cachexia and other muscle wasting disorders

16/01/2025 - 09:00

Fabio Dorigotti brings over 25 years of clinical development experience Joins Actimed following retirement of Frank Misselwitz London, UK – 16 January 2025. Actimed Therapeutics, a UK based clinical stage speciality [...]

KFSHRC Launches Precision Medicine Services in Family Medicine Clinics to Enhance Access to the Latest Genetic Tests

16/01/2025 - 10:52

RIYADH, Saudi Arabia, Jan. 16, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has launched precision medicine services within its Family Medicine Clinics, aiming to advance [...]

Outlook Therapeutics® Announces Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial

16/01/2025 - 12:00

ONS-5010 demonstrated to be non-inferior to Lucentis at 12 weeks BLA resubmission on track for calendar Q1 2025 Entered into agreements for warrant inducement transaction expected to result in up to $20.4 million in [...]

Micron Biomedical Extends Series A Financing to 33+ Million to Accelerate Commercialization of Needle-Free Therapeutics and Vaccines

16/01/2025 - 13:00

$16M extension round led by J2 Ventures and GHIC builds on support from BARDA, CEPI, the Bill & Melinda Gates Foundation and others to simplify access to life-saving drugs ATLANTA, Jan. 16, 2025 (GLOBE NEWSWIRE) -- [...]

Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to VOWST Sale

16/01/2025 - 13:00

CAMBRIDGE, Mass., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading live biotherapeutics company, announced today the receipt of a $50 million installment [...]

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

16/01/2025 - 13:00

WATERTOWN, Mass., Jan. 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious [...]

Avacta Announces Positive New Data from the AVA6000 Phase 1 trial Demonstrating Clinically Meaningful Tumor Shrinkage in Patients with Salivary Gland Cancers

16/01/2025 - 13:00

Meaningful tumor shrinkage observed in five out of 10 patients with partial and minor responses and 90% disease control rate in patients with salivary gland cancers Phase 1b expansion cohorts screening patients in [...]